THE INFLUENCE OF SPELEOTHERAPY ON BRONCHI PASSAGE IN CHILDREN WITH BRONCHIAL ASTHMA USING A PHARMACO-FUNCTIONAL TEST

Volodymyr M Bilak1, Lyudmila V Ignatko1, Natalya V Sochka1

  • 1STATE HIGHER EDUCATIONAL ESTABLISHMENT «UZHHOROD NATIONAL UNIVERSITY», UZHHOROD, UKRAINE.

Wiadomosci Lekarskie (Warsaw, Poland : 1960)
|April 14, 2023
PubMed

Insights

Speleotherapy improved bronchial asthma symptoms in children. It normalized bronchial tone and improved airway function in response to salbutamol (a bronchodilator) for those with intermittent and mild asthma.

Area of Science:

  • Pediatric Pulmonology
  • Environmental Medicine
  • Respiratory Physiology

Background:

  • Bronchial asthma is a chronic respiratory condition affecting children.
  • Asthma severity varies, impacting bronchial tone and patency.
  • Speleotherapy, a natural cave environment treatment, is explored for its therapeutic effects.

Purpose of the Study:

  • To evaluate the effect of speleotherapy on bronchial reactivity to salbutamol in children with different asthma severities.
  • To assess changes in bronchial tone and patency following speleotherapy.

Main Methods:

  • A study involving 40 children (6-15 years) with intermittent or mild asthma.
  • Pharmaco-functional testing (PFT) with salbutamol was used to assess external respiration function (FER).
  • Measurements were taken before and after speleotherapy, with comparisons to 40 healthy children.

Main Results:

  • Speleotherapy led to decreased bronchial tone and restored patency in all children with intermittent asthma.
  • Children with mild asthma showed a partial decrease in bronchial hyperreactivity and improved patency.
  • Positive bronchodilator response to salbutamol was observed post-speleotherapy.

Conclusions:

  • Speleotherapy positively influences bronchial response to salbutamol in pediatric asthma.
  • The treatment normalizes bronchial tone and restores patency, particularly in intermittent and mild asthma cases.
  • Speleotherapy offers a potential complementary therapy for managing childhood asthma.
Abstract

Related Concept Videos

Antiasthma Drugs: β2-Adrenoceptor Agonists01:25

Antiasthma Drugs: β2-Adrenoceptor Agonists

Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
323
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K
Antiasthma Drugs: Methylxanthines01:24

Antiasthma Drugs: Methylxanthines

Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
287
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
515
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
479
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by...
359